Moumita Dam

Evaluation of Lympho-vascular Invasion in Breast Carcinoma Using Lymphatic Endothelial Marker (D2-40)

Moumita Dam, Hemalatha Ganapathy & S. Mary Lilly · Journal of Pharmaceutical Research International · 2021

Breast cancer has become the most frequently diagnosed cancer and the leading cause of cancer-related death among women worldwide, overtaking lung cancer. The Present study attempts to investigate the use of D2 -40 for the detection of lympho- vascular invasion in node negative b...

Open access Research Article 10.9734/jpri/2021/v33i21B31375

Association of Lympho-vascular Invasion with Various Known Prognostic Markers in Breast Carcinomna

Moumita Dam & Hemalatha Ganapathy · Journal of Pharmaceutical Research International · 2020

Breast cancer is the one of the most frequent neoplasm in women. In the last decades, detection of disease in earlier clinical stages has improved prognosis, however five-year disease-free survival still remains at about 72%. For this reason, continuing efforts to establish relia...

Open access Research Article 10.9734/jpri/2020/v32i1230570